Rapport Therapeutics, Inc. Common Stock (RAPP) Stock Analysis

Rapport Therapeutics, Inc. Common Stock (RAPP) is a publicly traded company in the HEALTHCARE sector. It trades at $34.90, carries a market capitalization of $1.77B. This page summarizes the public market data, fundamentals, and frequently asked questions for RAPP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $34.90
• Market Cap: $1.77B
• EPS: $-2.60
• 52-Week High: $42.27
• 52-Week Low: $10.51

Market Sentiment

Rapport Therapeutics, Inc. Common Stock currently has a Bullish sentiment score of 0.28.

About Rapport Therapeutics, Inc. Common Stock

None

GNG Research Analysis

GNG Research scores Rapport Therapeutics, Inc. Common Stock (RAPP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RAPP.

Frequently Asked Questions

Does RAPP pay dividends?

Rapport Therapeutics, Inc. Common Stock (RAPP) does not currently pay a regular dividend.

What is RAPP's market cap?

Rapport Therapeutics, Inc. Common Stock (RAPP) has a market capitalization of $1.77B with a current stock price of $34.90.